To facilitate the identification of new candidate phytochemicals agents for their use as inhibitors of breast and lung cancer by targeting the Epidermal Growth Factor Receptor Tyrosine Kinase Domain (EGFR-TKD). The gene discussed is EGFR; the disease is lung carcinoma.